Biogen (BIIB) traders want calls after Buffett anounces position
Get Alerts BIIB Hot Sheet
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) 30-day option implied volatility is at 32; compared to its 52-week range of 25 to 54 after Warren Buffett’s Berkshire Hathaway (BRK-B) on Friday disclosed it took a new 648K share stake in the drugmaker. Call put ratio 2.4 calls to 1 put.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
- Target (TGT) puts more active than calls into quarter results
- ZoomInfo (GTM) 27K contracts of October 2 weekly 3 puts trade share price up 3.8%
Create E-mail Alert Related Categories
OptionsRelated Entities
Warren Buffett, OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share